Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sigyn Therapeutics's operating cash flow for the twelve months ending Sep 30, 2025 was -$936.43K. For fiscal 2024 it was -$872.44K. The highest annual figure on record is -$44.44K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$872.44K | – |
| FY2023 | Dec 31, 2023 | -$1.38M | – |
| FY2022 | Dec 31, 2022 | -$1.83M | – |
| FY2021 | Dec 31, 2021 | -$1.77M | – |
| FY2020 | Dec 31, 2020 | -$829.81K | – |
| FY2019 | Dec 31, 2019 | -$143.68K | – |
| FY2018 | Dec 31, 2018 | -$286.11K | – |
| FY2017 | Dec 31, 2017 | -$400.00K | – |
| FY2015 | Dec 31, 2015 | -$83.82K | – |
| FY2014 | Dec 31, 2014 | -$44.44K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | -$199.33K | – |
| Q2 FY2025 | Jun 30, 2025 | -$152.44K | – |
| Q1 FY2025 | Mar 31, 2025 | -$294.45K | – |
| Q4 FY2024 | Dec 31, 2024 | -$290.22K | – |
| Q3 FY2024 | Sep 30, 2024 | -$163.81K | – |
| Q2 FY2024 | Jun 30, 2024 | -$182.79K | – |
| Q1 FY2024 | Mar 31, 2024 | -$235.61K | – |
| Q4 FY2023 | Dec 31, 2023 | -$127.89K | – |
| Q3 FY2023 | Sep 30, 2023 | -$364.05K | – |
| Q2 FY2023 | Jun 30, 2023 | -$328.69K | – |
| Q1 FY2023 | Mar 31, 2023 | -$562.57K | – |
| Q4 FY2022 | Dec 31, 2022 | -$451.77K | – |
| Q3 FY2022 | Sep 30, 2022 | -$524.17K | – |
| Q2 FY2022 | Jun 30, 2022 | -$394.74K | – |
| Q1 FY2022 | Mar 31, 2022 | -$459.57K | – |
| Q4 FY2021 | Dec 31, 2021 | -$552.96K | – |
| Q3 FY2021 | Sep 30, 2021 | -$539.69K | – |
| Q2 FY2021 | Jun 30, 2021 | -$407.11K | – |
| Q1 FY2021 | Mar 31, 2021 | -$274.42K | – |
| Q4 FY2020 | Dec 31, 2020 | -$280.75K | – |
| Q3 FY2020 | Sep 30, 2020 | -$201.97K | – |
| Q2 FY2020 | Jun 30, 2020 | -$134.84K | -1798.4% |
| Q1 FY2020 | Mar 31, 2020 | -$212.25K | – |
| Q4 FY2019 | Dec 31, 2019 | -$30.01K | -343.6% |
| Q3 FY2019 | Sep 30, 2019 | -$48.78K | -263.1% |
| Q2 FY2019 | Jun 30, 2019 | $7.94K | – |
| Q1 FY2019 | Mar 31, 2019 | -$72.83K | – |
| Q4 FY2018 | Dec 31, 2018 | $12.32K | – |
| Q3 FY2018 | Sep 30, 2018 | $29.92K | +1330.8% |
| Q2 FY2018 | Jun 30, 2018 | -$6.51K | – |
| Q1 FY2018 | Mar 31, 2018 | -$321.84K | – |
| Q4 FY2017 | Dec 31, 2017 | -$218.95K | – |
| Q3 FY2017 | Sep 30, 2017 | $2.09K | – |
| Q2 FY2017 | Jun 30, 2017 | -$75.18K | – |
| Q1 FY2017 | Mar 31, 2017 | -$107.96K | – |
| Q3 FY2016 | Sep 30, 2016 | -$106.44K | – |
| Q2 FY2016 | Jun 30, 2016 | -$165.58K | – |
| Q1 FY2016 | Mar 31, 2016 | -$317.57K | – |
| Q4 FY2015 | Dec 31, 2015 | -$78.28K | – |
See a number that looks wrong?